ASPG and acute lymphoblastic leukemia: Recently, ATOMIC-meso reported an increase in the median overall and progression-free survival in patients randomised to ADIPEMCIS, representing the first positive phase 3 study of amino acid deprivation since the development of asparaginase for the treatment of acute lymphoblastic leukaemia in the 1960s (manuscript in preparation) [58].